Clinical Trials Logo
  1. Home
  2. Ischemic Stroke
  3. NCT06316557
  4. Details
NCT06316557 Clinical Trial

High-frequency rTMS on the Cerebellar to Improve Post-stroke Cognitive Impairment

Ischemic Stroke Clinical Trial

— HOPE  

Official title:
High-frequency Repetitive Transcranial Magnetic Stimulation on the Cerebellar Hemisphere to Improve Post-stroke Cognitive Impairment

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06316557
Other study ID # HX-A-2022063
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date April 1, 2027

Study information
Verified date March 2024
Source Beijing Tiantan Hospital
Contact Weili Jia, Dr.
Phone 13120207987
Email jiawl1994@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.

Description:

The primary objective of this clinical trial is to investigate the effectiveness and safety of high-frequency repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. The trial aims to answer two main questions: (1) What is the effectiveness of high-frequency rTMS in improving post-stroke cognitive impairment? (2) Is high-frequency rTMS in the cerebellum safe for individuals with post-stroke cognitive impairment? Participants will undergo 5Hz rTMS in the cerebellar opposite the lesion site, once daily for a total of five days. The control group will receive sham rTMS with the same parameters and positions. By comparing the effectiveness of rTMS for post-stroke cognitive impairment between the two groups, researchers will assess the potential benefits of rTMS.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 70
Est. completion date April 1, 2027
Est. primary completion date July 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Key inclusion criteria: (1)ischemic stroke, with an initial incident occurring within 2 weeks;(2)MoCA<26; Key exclusion criteria: (1)Cerebral hemorrhage or subarachnoid hemorrhage;(2)A pre-existing history of epilepsy;

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• rTMS group
5Hz rTMS in lesion contralateral cerebellar hemisphere, once a day for a total of five days
• control group
shame rTMS in lesion contralateral cerebellar hemisphere, once a day for a total of five days

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Beijing Tiantan Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary The efficacy of rTMS in improving cognitive function of post-stroke cognitive impairment The change of MoCA between baseline and 3 months follow-up 3 months follow-up after rTMS treatment
Secondary The safety of rTMS in improving cognitive function of post-stroke cognitive impairment Incidence of epilepsy during rTMS treatment day1-day7
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05518305 - Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Terminated NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Not yet recruiting NCT06462599 - Osteopontin Gene Polymorphism in Stroke Patients in Egypt
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Not yet recruiting NCT06032819 - Differentiating Between Brain Hemorrhage and Contrast
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Completed NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2